Hakkındaki gerçekler Global HIV Vaccine Enterprise
İnternet sitesi | vaccineenterprise.org |
Endüstri | non-profits & non-profit services |
Ülke | US |
Durum | New York |
Şehir | New York |
Telefon numarası | (212) 461-3692 |
Email pattern | {f}{last} |
Email Accept all Durum | False |
Email Blocked Durum | False |
Whois Oluşturulma tarihi | September 7th 2004, 02:51:06 pm |
RWhois | www.cloudflare.com... |
Whois Name | CloudFlare, Inc. |
Total Emails | 16 |
Total Personal Emails | 15 |
Total Generic Emails | 1 |
Last updated | April 4th 2023, 08:18:38 pm |
Herhangi bir web sitesinin arkasındaki herhangi birinin e-postasını bulun
Sosyal hesaplar Global HIV Vaccine Enterprise
Için tüm e-posta adresleri vaccineenterprise.org
randy goetzr***@vaccineenterprise.org | 5 Sources | |
amapola manriquea***@vaccineenterprise.org | associate director | 2 Sources |
alan bernsteina***@vaccineenterprise.org | 3 Sources | |
yegor voroniny***@vaccineenterprise.org | senior science officer | 1 Sources |
gabriella scarlattig***@vaccineenterprise.org | Science Director | 0 Sources |
iris corbassoni***@vaccineenterprise.org | 0 Sources | |
bill snowb***@vaccineenterprise.org | director | 0 Sources |
mark walportm***@vaccineenterprise.org | principal | 0 Sources |
bargavi thyagarajanb***@vaccineenterprise.org | Science Officer | 0 Sources |
karen jasiek***@vaccineenterprise.org | grants budget manager | 0 Sources |
6 Aramanız için daha fazlası vaccineenterprise.org
E-posta adreslerini ortaya çıkarmak, tüm sonuçları, arama filtrelerini, CSV indirmelerini ve daha fazlasını almak için bir hesap oluşturun.
E-posta Formatı
Pattern | # | |
---|---|---|
johndoe@vaccineenterprise.org | {first}{last} | No |
john.doe@vaccineenterprise.org | {first}.{last} | No |
john-doe@vaccineenterprise.org | {first}-{last} | No |
doejohn@vaccineenterprise.org | {last}{first} | No |
doe.john@vaccineenterprise.org | {last}.{first} | No |
doe-john@vaccineenterprise.org | {last}-{first} | No |
jdoe@vaccineenterprise.org | {f}{last} | Available |
j.doe@vaccineenterprise.org | {f}.{last} | No |
j-doe@vaccineenterprise.org | {f}-{last} | No |
johnd@vaccineenterprise.org | {first}{l} | No |
john.d@vaccineenterprise.org | {first}.{l} | No |
john-d@vaccineenterprise.org | {first}-{l} | No |
djohn@vaccineenterprise.org | {l}{first} | No |
d.john@vaccineenterprise.org | {l}.{first} | No |
d-john@vaccineenterprise.org | {l}-{first} | No |
doej@vaccineenterprise.org | {last}{f} | No |
doe.j@vaccineenterprise.org | {last}.{f} | No |
doe-j@vaccineenterprise.org | {last}-{f} | No |
john@vaccineenterprise.org | {first} | No |
doe@vaccineenterprise.org | {last} | No |
jd@vaccineenterprise.org | {f}{l} | No |
j.d@vaccineenterprise.org | {f}.{l} | No |
j-d@vaccineenterprise.org | {f}-{l} | No |
dj@vaccineenterprise.org | {l}{f} | No |
d.j@vaccineenterprise.org | {l}.{f} | No |
d-j@vaccineenterprise.org | {l}-{f} | No |